X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC LTD ELDER PHARMA/
ALEMBIC LTD
 
P/E (TTM) x -0.2 55.9 - View Chart
P/BV x 0.1 2.3 4.3% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ELDER PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC LTD
Mar-18
ELDER PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs38072 527.8%   
Low Rs18834 554.6%   
Sales per share (Unadj.) Rs491.24.7 10,449.6%  
Earnings per share (Unadj.) Rs-3.26.1 -52.1%  
Cash flow per share (Unadj.) Rs14.46.2 230.7%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.540.7 926.0%  
Shares outstanding (eoy) m20.54267.03 7.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.611.3 5.1%   
Avg P/E ratio x-89.38.7 -1,029.0%  
P/CF ratio (eoy) x19.78.5 232.5%  
Price / Book Value ratio x0.81.3 57.9%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m5,83314,139 41.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,179207 1,050.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0891,255 803.8%  
Other income Rs m257370 69.3%   
Total revenues Rs m10,3461,625 636.5%   
Gross profit Rs m-792111 -712.8%  
Depreciation Rs m36138 955.8%   
Interest Rs m2,7562 162,135.3%   
Profit before tax Rs m-3,653442 -826.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m12524 522.5%   
Profit after tax Rs m-651,630 -4.0%  
Gross profit margin %-7.88.9 -88.7%  
Effective tax rate %-3.45.4 -63.2%   
Net profit margin %-0.6129.8 -0.5%  
BALANCE SHEET DATA
Current assets Rs m9,2401,867 494.9%   
Current liabilities Rs m9,998591 1,691.1%   
Net working cap to sales %-7.5101.6 -7.4%  
Current ratio x0.93.2 29.3%  
Inventory Days Days4694 49.1%  
Debtors Days Days6074 81.5%  
Net fixed assets Rs m10,1241,791 565.3%   
Share capital Rs m206534 38.5%   
"Free" reserves Rs m5,58210,324 54.1%   
Net worth Rs m7,73410,858 71.2%   
Long term debt Rs m4,88941 11,866.5%   
Total assets Rs m22,88211,591 197.4%  
Interest coverage x-0.3260.9 -0.1%   
Debt to equity ratio x0.60 16,660.4%  
Sales to assets ratio x0.40.1 407.1%   
Return on assets %11.814.1 83.5%  
Return on equity %-0.815.0 -5.6%  
Return on capital %22.315.2 146.9%  
Exports to sales %3.01.5 196.6%   
Imports to sales %0.421.0 2.0%   
Exports (fob) Rs m30719 1,580.4%   
Imports (cif) Rs m43263 16.4%   
Fx inflow Rs m30719 1,580.4%   
Fx outflow Rs m125264 47.5%   
Net fx Rs m181-244 -74.2%   
CASH FLOW
From Operations Rs m11,754236 4,984.8%  
From Investments Rs m-561-224 250.2%  
From Financial Activity Rs m-6,762-27 25,420.3%  
Net Cashflow Rs m4,432-15 -29,943.9%  

Share Holding

Indian Promoters % 39.6 64.0 61.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 16.8 9.7 173.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.1 138.3%  
Shareholders   16,479 54,701 30.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  CIPLA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS